Edition:
United States

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

4.80USD
20 Jul 2018
Change (% chg)

$0.13 (+2.78%)
Prev Close
$4.67
Open
$4.67
Day's High
$4.85
Day's Low
$4.62
Volume
24,190
Avg. Vol
38,685
52-wk High
$18.17
52-wk Low
$4.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.471
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.312
Jun '17 0.00 -1.488
Mar '17 0.00 -0.279
FY 2016 Dec '16 0.00 -0.302
Sep '16 0.00 -0.516
Jun '16 0.00 -1.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 3 -0.58 -0.52 -0.61 --
Quarter Ending Dec-18 3 -0.62 -0.53 -0.68 --
Year Ending Dec-18 3 -2.23 -2.09 -2.35 --
Year Ending Dec-19 3 -2.38 -2.31 -2.48 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 43.98 33.34
P/E High - Last 5 Yrs. -- 41.28 47.12
P/E Low - Last 5 Yrs. -- 24.95 24.95
Beta -- 0.77 0.81
Price to Sales (TTM) -- 7.82 8.11
Price to Book (MRQ) 0.91 6.45 4.23
Price to Tangible Book (MRQ) 0.90 15.18 6.21
Price to Cash Flow (TTM) -- 28.04 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.85 1.72
Dividend Yield - 5 Year Avg -- 1.07 1.46
Dividend 5 Year Growth Rate -- 17.82 -6.39
Payout Ratio(TTM) -- 35.83 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 10.43 4.76
Sales (TTM) vs TTM 1 Yr. Ago -- 12.06 12.32
Sales - 5 Yr. Growth Rate -- 10.16 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -68.90 18.58 48.99
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 15.86 7.97
Capital Spending - 5 Yr. Growth Rate -- 7.33 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.56
Current Ratio (MRQ) 19.24 2.77 3.63
LT Debt to Equity (MRQ) 10.03 24.50 13.08
Total Debt to Equity (MRQ) 11.60 30.89 17.18
Interest Coverage (TTM) -- 25.53 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.27 55.23
Gross Margin - 5 Yr. Avg. -- 58.10 53.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 23.80 15.61
Operating Margin (TTM) -- 19.50 -0.70
Operating Margin - 5 Yr. Avg. -- 16.33 10.75
Pre-Tax Margin (TTM) -- 19.04 1.18
Pre-Tax Margin - 5 Yr. Avg. -- 16.10 10.87
Net Profit Margin (TTM) -- 14.74 -2.12
Net Profit Margin - 5 Yr. Avg. -- 11.17 7.23
Effective Tax Rate (TTM) -- 12.39 20.83
Effective Tax Rate - 5 Yr. Avg. -- 27.78 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 27,805,863 740,084,415
Net Income/Employee (TTM) -953,000 3,564,923 86,307,671
Receivable Turnover (TTM) -- 4.83 5.95
Inventory Turnover (TTM) -- 3.29 3.69
Asset Turnover (TTM) -- 0.77 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.93 10.36
Return on Assets - 5 Yr. Avg. -- 9.61 11.03
Return on Investment (TTM) -- 14.54 13.18
Return on Investment - 5 Yr. Avg. -- 12.51 14.26
Return on Equity (TTM) -- 17.68 15.09
Return on Equity - 5 Yr. Avg. -- 15.11 15.57
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 7.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for scPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.05%
# of Holders: 60
Total Shares Held: 14,843,569
3 Mo. Net Change: -36,005
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 3
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.